Mapping how light-sensing proteins move in eye cells
Molecular -Scale Mapping of Rhodopsin Trafficking in Mammalian Rod Photoreceptors
['FUNDING_OTHER'] · WEST VIRGINIA UNIVERSITY · NIH-11047700
This study is looking at how a key protein for vision, called rhodopsin, moves and gets renewed in the cells of the retina, which is important for people with vision problems, to find new ways to help treat eye diseases.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WEST VIRGINIA UNIVERSITY (nih funded) |
| Locations | 1 site (MORGANTOWN, UNITED STATES) |
| Trial ID | NIH-11047700 on ClinicalTrials.gov |
What this research studies
This research investigates the movement and renewal of rhodopsin, a crucial protein for vision, within rod photoreceptor cells in the retina. By examining the cellular pathways and structures involved in rhodopsin trafficking, the study aims to uncover mechanisms that could lead to vision loss when disrupted. The approach includes advanced molecular mapping techniques to visualize how rhodopsin is synthesized and transported to the outer segment of these cells. Understanding these processes may reveal new targets for therapies aimed at retinal diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic predispositions to retinal diseases or those experiencing early symptoms of vision loss.
Not a fit: Patients with retinal conditions unrelated to rhodopsin trafficking may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for retinal diseases that cause vision loss, such as retinitis pigmentosa.
How similar studies have performed: While the specific pathways being investigated are less studied, similar research has shown promise in understanding protein trafficking in other cell types, indicating potential for success.
Where this research is happening
MORGANTOWN, UNITED STATES
- WEST VIRGINIA UNIVERSITY — MORGANTOWN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROBICHAUX, MICHAEL — WEST VIRGINIA UNIVERSITY
- Study coordinator: ROBICHAUX, MICHAEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.